Medroxyprogesterone [Design Issues]

posted by Dr_Dan  – Germany, 2016-03-10 10:11 (3764 d 07:25 ago) – Posting: # 16084
Views: 6,052

Dear Ratnakar
The sampling schemes are more or less the same, WHO presents in days, FDA in hours. The only difference is a tighter sampling interval at day one in order to detect the initial peak suggested by the FDA and sampling twice per day for the first week suggested by WHO. I did a combination of both.
I hope this helps.
Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
315 visitors (0 registered, 315 guests [including 24 identified bots]).
Forum time: 18:37 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5